Current Neuropharmacology

Papers
(The H4-Index of Current Neuropharmacology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction157
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease118
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury116
Childhood Trauma and Self-harm in Youths with Bipolar Disorders101
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats94
Neurobiological Mechanisms Underlying Hippocampal Dysfunction in Post-Traumatic Stress Disorder77
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential76
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring71
Role of Glycerophospholipid Metabolism in Epilepsy68
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study67
GLP-1 Receptor Agonists in Neuropathic Pain and Neurodegenerative Diseases: Mechanisms, Therapeutic Potentials, and Future Perspectives65
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study65
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome64
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 201762
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS62
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management61
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder61
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)56
Meet the Editorial Board Member55
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy55
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases53
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase50
Myeloid-derived Suppressor Cells and Multiple Sclerosis50
CREB-Mediated Regulation of Microglial Polarization in Central Nervous System Diseases49
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis46
Recent Advances in Guillain-Barré Syndrome: Neurological Disorder, Pathophysiology, Diagnosis, Treatment, and Challenges44
Targeting the Kynurenine Pathway to Improve Mood Disorders44
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression43
Brivaracetam in Refractory Epilepsy: Mechanism, Tolerability, and Clinical Positioning42
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study40
Rejuvenating Inter-organellar Communication Via Mitophagy in Ageing and Neurodegeneration39
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics39
What is the Role of Lithium in Epilepsy?39
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation38
Current Insights of Muscone: Source, Quality Control, and Protection Mechanism of Cerebral Ischemic Injury37
Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies36
0.20852422714233